Amedisys Gross Margin 2010-2024 | AMED

Current and historical gross margin for Amedisys (AMED) over the last 10 years. The current gross profit margin for Amedisys as of March 31, 2024 is %.
Amedisys Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $2.25B $1.00B 44.42%
2023-12-31 $2.24B $0.99B 44.32%
2023-09-30 $2.23B $0.99B 44.32%
2023-06-30 $2.23B $0.98B 43.88%
2023-03-31 $2.23B $0.96B 43.15%
2022-12-31 $2.22B $0.96B 43.32%
2022-09-30 $2.22B $0.96B 43.24%
2022-06-30 $2.22B $0.97B 43.66%
2022-03-31 $2.23B $0.99B 44.25%
2021-12-31 $2.23B $0.99B 44.63%
2021-09-30 $2.23B $1.00B 45.08%
2021-06-30 $2.22B $1.01B 45.52%
2021-03-31 $2.16B $0.96B 44.63%
2020-12-31 $2.11B $0.92B 43.73%
2020-09-30 $2.05B $0.88B 42.68%
2020-06-30 $2.00B $0.83B 41.58%
2020-03-31 $1.98B $0.82B 41.34%
2019-12-31 $1.96B $0.81B 41.16%
2019-09-30 $1.89B $0.77B 40.87%
2019-06-30 $1.81B $0.73B 40.53%
2019-03-31 $1.73B $0.70B 40.52%
2018-12-31 $1.66B $0.67B 40.31%
2018-09-30 $1.63B $0.66B 40.41%
2018-06-30 $1.58B $0.64B 40.11%
2018-03-31 $1.55B $0.62B 40.10%
2017-12-31 $1.51B $0.61B 40.15%
2017-09-30 $1.46B $0.58B 39.81%
2017-06-30 $1.45B $0.59B 40.34%
2017-03-31 $1.44B $0.59B 40.74%
2016-12-31 $1.42B $0.58B 41.13%
2016-09-30 $1.41B $0.60B 42.27%
2016-06-30 $1.37B $0.59B 42.72%
2016-03-31 $1.33B $0.57B 43.03%
2015-12-31 $1.28B $0.56B 43.36%
2015-09-30 $1.24B $0.54B 43.28%
2015-06-30 $1.22B $0.53B 43.39%
2015-03-31 $1.21B $0.52B 43.21%
2014-12-31 $1.21B $0.51B 42.57%
2014-09-30 $1.21B $0.51B 42.09%
2014-06-30 $1.21B $0.50B 41.72%
2014-03-31 $1.22B $0.51B 41.84%
2013-12-31 $1.25B $0.53B 42.51%
2013-09-30 $1.29B $0.56B 43.21%
2013-06-30 $1.35B $0.59B 43.49%
2013-03-31 $1.40B $0.61B 43.60%
2012-12-31 $1.44B $0.63B 43.65%
2012-09-30 $1.42B $0.63B 44.29%
2012-06-30 $1.42B $0.64B 44.87%
2012-03-31 $1.43B $0.66B 46.05%
2011-12-31 $1.42B $0.67B 47.14%
2011-09-30 $1.46B $0.71B 48.42%
2011-06-30 $1.49B $0.74B 49.30%
2011-03-31 $1.55B $0.77B 49.77%
2010-12-31 $1.60B $0.81B 50.41%
2010-09-30 $1.62B $0.82B 50.62%
2010-06-30 $1.60B $0.83B 51.59%
2010-03-31 $1.56B $0.81B 52.15%
2009-12-31 $1.48B $0.78B 52.49%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.184B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00